BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

750 related articles for article (PubMed ID: 29162158)

  • 1. Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer.
    YiRen H; YingCong Y; Sunwu Y; Keqin L; Xiaochun T; Senrui C; Ende C; XiZhou L; Yanfan C
    Mol Cancer; 2017 Nov; 16(1):174. PubMed ID: 29162158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
    Zhang YF; Li CS; Zhou Y; Lu XH
    Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2.
    An Y; Zhang Z; Shang Y; Jiang X; Dong J; Yu P; Nie Y; Zhao Q
    Cell Death Dis; 2015 May; 6(5):e1766. PubMed ID: 25996293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
    Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
    Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
    Xi Z; Si J; Nan J
    Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer.
    Luo M; Deng X; Chen Z; Hu Y
    Cell Death Dis; 2023 Jan; 14(1):10. PubMed ID: 36624091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-21R functions as an oncogenic factor and is regulated by the lncRNA MALAT1/miR-125a-3p axis in gastric cancer.
    Yan L; Zhang J; Guo D; Ma J; Shui SF; Han XW
    Int J Oncol; 2019 Jan; 54(1):7-16. PubMed ID: 30387833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis.
    Ren N; Jiang T; Wang C; Xie S; Xing Y; Piao D; Zhang T; Zhu Y
    Aging (Albany NY); 2020 Jun; 12(11):11025-11041. PubMed ID: 32516127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. lncRNA SNHG11 Promotes Gastric Cancer Progression by Activating the Wnt/β-Catenin Pathway and Oncogenic Autophagy.
    Wu Q; Ma J; Wei J; Meng W; Wang Y; Shi M
    Mol Ther; 2021 Mar; 29(3):1258-1278. PubMed ID: 33068778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low SP1 SUMOylation-dependent SNHG17 upregulation promotes drug resistance of gastric cancer through impairing hsa-miR-23b-3p-induced Notch2 inhibition.
    Huang G; Cai G; Hu D; Li J; Xu Q; Chen Z; Xu B
    Cell Oncol (Dordr); 2022 Dec; 45(6):1329-1346. PubMed ID: 36214997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALAT1 Mediates
    Geng X; Zou Y; Li S; Qi R; Yu H; Li J
    Mediators Inflamm; 2023; 2023():4477492. PubMed ID: 37064502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.
    Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z
    Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
    J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.
    Li G; Zhang Z; Chen Z; Liu B; Wu H
    Life Sci; 2021 Jul; 277():119419. PubMed ID: 33785336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer.
    Sun W; Li J; Zhou L; Han J; Liu R; Zhang H; Ning T; Gao Z; Liu B; Chen X; Ba Y
    Theranostics; 2020; 10(5):1981-1996. PubMed ID: 32104496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361.
    Wu X; Zheng Y; Han B; Dong X
    Biomed Pharmacother; 2018 Mar; 99():832-838. PubMed ID: 29710482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
    Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
    Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke.
    Guo D; Ma J; Yan L; Li T; Li Z; Han X; Shui S
    Cell Physiol Biochem; 2017; 43(1):182-194. PubMed ID: 28854438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MALAT1 promotes gastric cancer progression via inhibiting autophagic flux and inducing fibroblast activation.
    Wang Z; Wang X; Zhang T; Su L; Liu B; Zhu Z; Li C
    Cell Death Dis; 2021 Apr; 12(4):368. PubMed ID: 33824303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism of the Canonical Oncogenic lncRNA MALAT1 in Gastric Cancer.
    Xu W; Ding M; Wang B; Cai Y; Guo C; Yuan C
    Curr Med Chem; 2021; 28(42):8800-8809. PubMed ID: 34036905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.